1-800-PetMeds

The Wine Messenger

Overstock.com, Inc.

Office Depot, Inc

Last updated 2/10/09



Senior ‘Safe House’ Nears Completion

Economic Stimulus Package Good for Seniors?

Blue Collar Man Leads Local Football Team to Victory

CBO Report Bad News for Social Security

Senior Health: Does the Failing Economy Have an Impact on Our Health?

Ted Ruhig: Seniors, Be Prepared for a New Economy

Ken's Corner: Jonah Was a Whiner, But the Cows Got the Last Laugh

This Week's Columnists

SENIOR LINKS

HOME

 

Local Researchers Seek Alzheimer’s Clues

By Stephen Baetge
Staff writer

A new research study at nearby UC Davis may lead to earlier detection of Alzheimer’s disease and allow greater insight into how the disease progresses in those suffering from its effects.

The innovative study attempts to determine whether closer examination of magnetic resonance imaging (MRI) scans can detect the onset of Alzheimer’s disease before patients begin to show symptoms and to predict how quickly those struck by the disease will lose their ability to think and reason.

Alzheimer’s is the most common form of dementia, and it affects approximately 5 million Americans. It destroys brain cells and causes a loss of memory, logical reasoning and other mental skills. There is no cure for the disease, although some studies have indicated that the effects of the disease can be mitigated.

Currently, there is no way to accurately detect early stage Alzheimer’s. Physicians use a series of cognitive tests in an attempt to diagnose the disease. Since some memory loss is a normal part of the aging process, it is difficult to determine early on if a person has Alzheimer’s.

MRI imaging is a diagnostic tool that can detect atrophy of a portion of the brain which is vital to learning and memory. But some atrophy — or shrinkage — of the brain occurs as a result of normal aging.

Owen Carmichael, principal investigator for the UC Davis study, hopes to use MRI to detect the distinct pattern of shrinkage that occurs in the brains of Alzheimer’s patients.

“We want to ‘squeeze more juice’ out of MRIs that are used to detect the presence of Alzheimer’s disease,” explained Carmichael, an assistant professor in the Department of Neurology and an adjunct professor in the Department of Computer Science. “We also want to predict the likely rate of decline.”

Carmichael and his colleagues will test a new, computational method of measuring atrophy in various regions of the brain to see whether Alzheimer’s produces distinct patterns of atrophy that can distinguish it from other patterns of impairment.

“We hope that by using this technique, we can provide a method for differentiating people who will experience healthy cognitive aging from those who will experience cognitive decline due to diseases like Alzheimer’s. For those who will experience cognitive decline, we hope to predict its rate of progression,” Carmichael said.

The UC Davis study uses a new computational MRI imaging method called Localized Components and Analysis (LoCA), developed by Carmichael and colleagues Nina Amenta, an associate professor in the Department of Computer Science, and computer science graduate student Dan Alcantara.

The researchers will use LoCA to analyze MRI scans of 800 adults who are part of a large, publicly available database. The database contains more than 4,000 MRI scans of the brains of patients diagnosed with Alzheimer’s, adults with mild brain impairment and those without symptoms.

The analysis will examine whether the patterns of brain atrophy differ among the three groups.

The analysis will also include a detailed examination of the MRI brain scans of adults tested using experimental imaging tests that try to detect aspects of Alzheimer’s pathology in the brain to determine whether LoCA can tell the difference between those who appear to have the pathology and those that do not.

Researchers will use the results of these comparisons to analyze additional MRI scans to see whether the method can predict rates of cognitive decline in Alzheimer’s.

“Once diagnosed, patients, physicians and families have no reliable method for anticipating how fast cognitive functioning will decline,” Carmichael said. “We hope that this method will change that.”

The UC Davis study is funded by a three-year, $200,000 grant from the Dana Foundation.


TOP | HOME

 

 



This page and its contents ©2009 Metropolitan News Company, Inc.